NCT02022137 Fructans, Lactitol and Lactose in Minimal Hepatic Encephalopathy Status COMPLETED Phase NA
NCT02021253 Influence of Probiotics Administration Before Liver Resection in Liver Disease Status COMPLETED Phase NA
NCT02019784 Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy Status COMPLETED Phase PHASE4
NCT02011932 Prospective Observational Study of Disease Progression in Chronic Hepatitis C Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01951209 Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In Cirrhosis Status TERMINATED Phase NA
NCT01943617 Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis Status COMPLETED Phase PHASE4
NCT01942915 Umbilical Cord Blood Mononuclear Cells Therapy in Liver Cirrhosis Status UNKNOWN Phase PHASE1
NCT01938820 Optimized Treatment and Regression of HBV-induced Early Cirrhosis Status COMPLETED Phase PHASE4
NCT01937130 Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF Status TERMINATED Phase PHASE2
NCT01909778 Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis Status COMPLETED Phase PHASE1
NCT01904409 Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis Status COMPLETED Phase PHASE2
NCT01897051 Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients Status UNKNOWN Phase PHASE2/PHASE3
NCT01877759 A Clinical Study to Evaluate the Safety and Efficacy of Mesenchymal Stem Cells in Liver Cirrhosis Status UNKNOWN Phase PHASE1/PHASE2
NCT01872793 Validation of BIVA for Nutritional Assessment in Cirrhotic Patients Status COMPLETED Phase N/A
NCT01850940 Efficacy and Safety of Tolvaptan in Cirrhotic Patients With Hyponatremia Status COMPLETED Phase N/A
NCT01846949 Surveillance Study for HCC by Combining Biomarkers With Imaging (ALDUS) Status UNKNOWN Phase N/A